700 patients110,866 observations180 daysLIVE

Patient P-02599

Synthetic patientMETA-24 · Day 169 · 75+ · F · baseline S14Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
55%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S14
  2. Day 15 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 22 HY-01 recommendedHydration Protocol HY-01
  4. Day 23 Patient acceptedStarted HY-01 in the companion
  5. Day 27 GI symptom burden −12% vs expectedHydration Protocol HY-01
  6. Day 33 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 15.

Primary contributors, last 14 days
  • GI instability+20
  • Nutritional resilience-9
  • Inflammatory activity+8
  • Treatment adherence+6
  • Toxicity-2

What helped?

  • Hydration Protocol HY-01Day 22
    Result: symptom burden −12%
LIFE OS recommendation
Clinician Review CR-01
81%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 100% showed improvement
  • median effect visible after 5 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
61 min
worsening · -5.7 vs previous 14 d
Sleep duration
Wearable
7.7 h
stable · -0.2 vs previous 14 d
Energy level
Daily log
6/10
worsening · -0.8 vs previous 14 d
Steps
Wearable
6,575
worsening · -589 vs previous 14 d
GI burden
Companion
35.3/100
worsening · +15.3 vs previous 14 d
Adherence
Companion
94.9 %
stable · -2.4 vs previous 14 d
Sleep quality
Wearable
55.8/100
worsening · -5.1 vs previous 14 d
Glucose, CGM daily mean
CGM
126 mg/dL
worsening · +7.4 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 58 from the failing basin, 31 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
  • More protein
    GI -5.1 next day on high-intake days · n 19
Would not help
  • Keep fat low
    GI +5.4 next day on high-intake days · n 23
  • Keep ultra-processed low
    GI +5.2 next day on high-intake days · n 19
  • Keep caffeine low
    GI +4.1 next day on high-intake days · n 22
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +5.4detractor · 95%
  • Ultra-processed food
    +5.2detractor · 95%
  • Protein
    -5.1supporter · 95%
  • Caffeine
    +4.1detractor · 95%
  • Simple carbohydrates
    +3.9detractor · 95%
  • Histamine load
    +1.2no signal · 25%
  • Alcohol
    +1no signal · 22%
  • Insoluble fibre
    +0.3no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 60
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • MicrobiomeBacteroides fragilis expansion
    • WearableHRV 35 ms, trending down
  • Drug metabolism and exposure 40
    • DNACYP2D6 poor metabolizer → higher exposure
  • Butyrate / short-chain fatty acid production 35
    • MicrobiomeButyrate capacity 39/100
  • Mucosal barrier integrity 30
    • MicrobiomeAkkermansia low → thinner mucus layer
  • Autonomic recovery 25
    • WearableResting HR 75 bpm
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Poor metabolizer
    Higher exposure at standard dose
Microbiome
Shannon diversity 2.4 · butyrate capacity 39/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
41 ms
Sleep
7.1 h
Steps
6,946
Resting HR
73 bpm
Daily log: GI score 35, nutritional resilience 55, adherence 95.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0202350%S0746
P-0221950%S1360
P-0203349%S06GI-04improved51
P-0223549%S14DT-01improved50
P-0264549%S02HY-01improved56
P-0227448%S15DT-01improved50
P-0235148%S1651
P-0239448%S1262
P-0270048%S0262
P-0203747%S04GI-04improved53
P-0263947%S0858
P-0215046%S11HY-01improved45